The Run of His Life

Jeffrey Toobin’s "The Run of His Life: The People v. O. J. Simpson," published in 1996, remains one of the most detailed journalistic accounts of the murders of Nicole Brown Simpson and Ronald Goldman and the ensuing criminal trial. A staff writer at The New Yorker and former federal prosecutor, Toobin covered the case from before Simpson’s arrest through the October 1995 verdict, drawing on court records, internal legal strategy, and hundreds of interviews with lawyers, jurors, and investigators. The book is organized primarily around the prosecution and defense teams rather than the defendant himself, treating the trial as a collision of ambitious attorneys, media saturation, and racial fault lines in Los Angeles. Toobin’s central argument is that the prosecution lost less because of a single forensic failure than because of a cumulative series of misjudgments. He gives sustained attention to lead prosecutor Marcia Clark and her colleague Christopher Darden, whose decision to have Simpson try on the bloody glove became a defining moment of the trial, and to defense attorneys Johnnie Cochran, Robert Shapiro, F. Lee Bailey, and Alan Dershowitz, whose “dream team” strategy shifted the case from physical evidence toward police misconduct and reasonable doubt. He examines the role of LAPD detective Mark Fuhrman, the racial politics surrounding the jury, and the way cameras in the courtroom transformed the proceeding into a national spectacle. The title comes from a line in a note Simpson left before his slow-speed Bronco chase, and Toobin uses it to frame Simpson’s flight as an attempt to escape both legal and public judgment. Rather than a neutral procedural, the book advances a clear thesis: prosecutorial overconfidence, defense ingenuity, and the city’s racial history combined to produce an acquittal that many Americans found inexplicable. Widely cited as a definitive early account, it later helped shape the FX series "The People v. O. J. Simpson" and remains a standard law-shelf study of how high-profile trials can go wrong.